HIKMA PHARMACEUTICALS PLC ORD SHS 10P
Hikma Pharmaceuticals is a pharmaceutical company specializing in the manufacturing of generic and injectable medicines for various global markets.
Price history of HIKMA PHARMACEUTICALS PLC ORD SHS 10P
Price history of HIKMA PHARMACEUTICALS PLC ORD SHS 10P
Performance & Momentum
Strategic Analysis
HIKMA PHARMACEUTICALS PLC ORD SHS 10P • 2026
Hikma Pharmaceuticals is a global specialist in generic and injectable medicines, with a presence focused on essential healthcare segments where demand remains relatively defensive. Its positioning is built on an industrial offering subject to significant regulatory constraints, combining scale, manufacturing expertise and the ability to address multiple international markets.
- Exposure to structurally resilient healthcare markets
- Positioning in injectables, a more technical segment and often less commoditized than standard generics
- Diversified global portfolio, reducing dependence on any single market
- Intense competitive pressure in generics, which limits pricing power
- Deteriorated share performance over several time horizons, reflecting market lack of confidence in the operational momentum
- Business exposed to regulatory, industrial and supply chain constraints
Momentum appears favorable in the short term, but in a context that remains fragile given the clearly negative underlying trend over one, three and five years. Strategically, this suggests a potential technical rebound rather than a deep re-rating of the case, with the market waiting for evidence of profitability stabilization and execution before materially reassessing the group's defensive profile.
Similar stocks to HIKMA PHARMACEUTICALS PLC ORD SHS 10P
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
